Successful use of mepolizumab for severe hypereosinophilic vasculitis with c-ANCA positivity in a previously healthy 7-year-old boy

An unusual case of a pediatric patient with severe eosinophilic vasculitis causing digital ischemia is reported. The patient responded well to the anti–IL-5 agent mepolizumab, lending support for use of mepolizumab in pediatric patients with hypereosinophilic syndromes.

Detalles Bibliográficos
Autores principales: Fox, Eryn, Cohen, Barrie, Treyster, Zoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509853/
https://www.ncbi.nlm.nih.gov/pubmed/37780105
http://dx.doi.org/10.1016/j.jacig.2022.09.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509853/
https://www.ncbi.nlm.nih.gov/pubmed/37780105
http://dx.doi.org/10.1016/j.jacig.2022.09.009

Ejemplares similares